• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Prana Biotechnology Ltd

+ Add to Watchlist

PBT:AU

0.2500 AUD 0.0050 1.96%

As of 01:59:50 ET on 08/01/2014.

Snapshot for Prana Biotechnology Ltd (PBT)

Open: 0.2450 Day's Range: 0.2400 - 0.2550 Volume: 330,492
Previous Close: 0.2550 52wk Range: 0.1550 - 1.3700 1-Yr Rtn: -30.56%

Stock Chart for PBT

No chart data available.
  • PBT:AU 0.2500
  • 1D
  • 1M
  • 1Y
0.2550
Interactive PBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PBT

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0302
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M AUD) 122.16
Shares Outstanding (M) 488.65
30 Day Average Volume 426,425
Price/Book (mrq) 5.2609
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PBT

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PBT

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Geoffrey P KemplerChairman/CEO/FounderRichard RevelinsCFO/Secretary
Diane AngusChief Operating OfficerRudolph E Tanzi "Rudy"Chief Scientific Advisor
More Company Profile & Key Executives for PBT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil